Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 2
2012 5
2013 4
2015 7
2016 7
2017 5
2018 8
2019 5
2020 1
2021 3
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa.
Ntshiqa T, Chihota V, Mansukhani R, Nhlangulela L, Velen K, Charalambous S, Maenetje P, Hawn TR, Wallis R, Grant AD, Fielding K, Churchyard G. Ntshiqa T, et al. Among authors: chihota v. Gates Open Res. 2022 Aug 18;5:66. doi: 10.12688/gatesopenres.13191.3. eCollection 2021. Gates Open Res. 2022. PMID: 37560544 Free PMC article.
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB).
Malhotra A, Nonyane BAS, Shirey E, Mulder C, Hippner P, Mulatu F, Ratshinanga A, Mitiku P, Cohn S, Conradie G, Chihota V, Chaisson RE, Churchyard GJ, Golub J, Dowdy D, Sohn H, Charalambous S, Bedru A, Salazar-Austin N. Malhotra A, et al. Among authors: chihota v. Trials. 2023 Jul 25;24(1):475. doi: 10.1186/s13063-023-07514-7. Trials. 2023. PMID: 37491264 Free PMC article. Clinical Trial.
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus.
Jarrett RT, van der Heijden Y, Shotwell MS, Chihota V, Marzinke MA, Chaisson RE, Dooley KE, Churchyard GJ. Jarrett RT, et al. Among authors: chihota v. Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0129722. doi: 10.1128/aac.01297-22. Epub 2023 Jan 9. Antimicrob Agents Chemother. 2023. PMID: 36622148 Free PMC article.
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.
Simmons JD, Dill-McFarland KA, Stein CM, Van PT, Chihota V, Ntshiqa T, Maenetje P, Peterson GJ, Benchek P, Nsereko M, Velen K, Fielding KL, Grant AD, Gottardo R, Mayanja-Kizza H, Wallis RS, Churchyard G, Boom WH, Hawn TR. Simmons JD, et al. Among authors: chihota v. mSphere. 2022 Jun 29;7(3):e0015922. doi: 10.1128/msphere.00159-22. Epub 2022 Jun 13. mSphere. 2022. PMID: 35695527 Free PMC article.
Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.
Shilton S, Markby J, Japaridze M, Chihota V, Shadaker S, Gvinjilia L, Tsereteli M, Alkhazashvili M, Butsashvili M, Stvilia K, Ruiz RJ 3rd, Asatiani A, Adamia E, Easterbrook P, Khonelidze I, Gamkrelidze A. Shilton S, et al. Among authors: chihota v. Liver Int. 2022 Apr;42(4):775-786. doi: 10.1111/liv.15191. Epub 2022 Feb 18. Liver Int. 2022. PMID: 35129278 Free PMC article.
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Churchyard G, Cárdenas V, Chihota V, Mngadi K, Sebe M, Brumskine W, Martinson N, Yimer G, Wang SH, Garcia-Basteiro AL, Nguenha D, Masilela L, Waggie Z, van den Hof S, Charalambous S, Cobelens F, Chaisson RE, Grant AD, Fielding KL; WHIP3TB Study Team. Churchyard G, et al. Among authors: chihota v. Ann Intern Med. 2021 Oct;174(10):1367-1376. doi: 10.7326/M20-7577. Epub 2021 Aug 24. Ann Intern Med. 2021. PMID: 34424730 Clinical Trial.
Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion.
Simmons JD, Van PT, Stein CM, Chihota V, Ntshiqa T, Maenetje P, Peterson GJ, Reynolds A, Benchek P, Velen K, Fielding KL, Grant AD, Graustein AD, Nguyen FK, Seshadri C, Gottardo R, Mayanja-Kizza H, Wallis RS, Churchyard G, Boom WH, Hawn TR. Simmons JD, et al. Among authors: chihota v. J Clin Invest. 2021 Jul 15;131(14):e140073. doi: 10.1172/JCI140073. J Clin Invest. 2021. PMID: 34111032 Free PMC article. Clinical Trial.
55 results